Production of plasma-derived medicinal products: Ethical implications for blood donation and donors

Blood Transfusion

Volumn 12, Issue SUPPL.1, 2014, Pages

  Petrini, Carlo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Bioethics; Blood; Plasma derived medicinal products

Indexed keywords

ALTRUISM; BIOETHICS; BIOLOGICAL PRODUCTS; BLOOD BANKS; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DEVELOPING COUNTRIES; HUMAN RIGHTS; HUMANS; ITALY; PRESERVATION, BIOLOGICAL; PRIVATE SECTOR; PUBLIC SECTOR; REMUNERATION; SOCIAL VALUES; SOCIETIES, SCIENTIFIC;

EID: 84885663634     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.0167-12     Document Type: Review

References (36)

1. Steffen M. Sang Contaminé. Gestion d'une Crise Médicale. In: Lecourt D, editor. Dictionnaire de la Pensée Médicale. Paris: Presses Universitaires de France; 2004. p. 998-1005.
2. Biale D. Blood and Belief. The Circulation of a Symbol Between Jews and Christians. Berkeley: University of California Press; 2007.
3. Esposito R. Interview. Diacritics 2006; 36: 49-56.
4. Titmuss RM. The Gift Relationship: from Human Blood to Social Policy. London: Allen and Unwin; 1970.
5. Brown N, Machin L, McLeod D. Immunitary bioeconomy: the economisation of life in the international cord blood market. Soc Sci Med 2011; 72: 1115-22.
6. Italian Ministry of Health. Decree of 12 April, 2012. Modalitàper la presentazione e valutazione delle istanze volte ad ottenere l'inserimento tra i centri e le aziende di produzione di medicinali emoderivati autorizzati alla stipula delle convenzioni con le Regioni e le Province Autonome per la lavorazione del plasma raccolto sul territorio nazionale. Gazzetta Ufficiale della Repubblica Italiana - Serie Generale 26 June, 2012; 147.
7. Italian Ministry of Health. Decree of 12 April, 2012. Disposizioni sull'importazione ed esportazione del sangue umano e dei suoi prodotti. Gazzetta Ufficiale della Repubblica Italiana - Serie Generale 26 June, 2012; 147.
8. Italian Ministry of Health. Decree of 12 April, 2012 . Schema tipo di convenzione tra le Regioni e le Provincie Autonome e le Aziende produttrici di emoderivati per la lavorazione del plasma raccolto sul territorio nazionale. Gazzetta Ufficiale della Repubblica Italiana - Serie Generale 26 June, 2012; 147.
9. Italian Ministry of Health. Decree of 12 April, 2012. Modalitàtransitorie per l'immissione in commercio dei medicinali emoderivati prodotti dal plasma umano raccolto sul territorio nazionale. Gazzetta Ufficiale della Repubblica Italiana - Serie Generale 26 June 2012; 147.
10. WHO Expert Group. Expert Consensus statement on achieving self-sufficiency in safe blood and blood products based on voluntary non-remunerated blood donations (VNRBD). Vox Sang 2012; 103: 337-42.
11. O'Mahony, Turner A. The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. Vox Sang 2010; 98: 447-50.
12. O'Mahony B, Turner A. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products. Vox Sang 2012; 102: 140-3.
13. Mauss M. Essai sur le Don. Forme et Raison de l'Échange dans les Sociétés Archaïques.(I ed: 1924). Paris: Presses Universitaires de France; 2001.
14. Marion Jean-Luc. Étant Donné. Essai d'une Phénoménologie de la Donation.Paris: Presses Universitaires de France; 2005
15. World Health Organization. Global Database on Blood Safety. GDBS summary Report 2011. www.who.int/entity/bloodsafety/ global-database/GDBS-Summary- report-2011.pdf. Accessed on 01/06/2012.
16. World Health Organization. Availability, safety and quality of blood products. Sixty-third World Health Assembly. 21 May 2010. WHA63.12. Agenda item 11.17. http://apps.who.int/gb/ebwha/ pdf-files/WHA63/A63-r12-en.pdf. Accessed on 01/06/2012.
17. World Health Organization. Availability, safety and quality of blood products. Report by the Secretariat. Sixty-third World Health Assembly. WHA63/20. 25 March 2010. Agenda item 11.17. http://apps.who.int/gb/ebwha/pdf- files/WHA63/A63-20-en.pdf. Accessed on 01/06/2012.
18. World Health Organization. Global consultation on universal access to safe blood transfusion. Ottawa, 9-11 June 2007. www. who.int/entity/bloodsafety/ ReportOttawaConsultation2007.pdf. Accessed on 01/06/2012.
19. La farmacéutica Grifols pide legalizar el pago por donaciones de sangre. CincoDias. 18 April 2012. http://www.cincodias. com/articulo/empresas/ farmaceutica-grifols-pide-legalizarpago- donaciones-sangre/20120418cdscdiemp-18/ Accessed on 01/06/2012.
20. European Group on Ethics in Science and New Technologies [Group of Advisers on the Ethical Implications of Biotechnology to the European Commission]. Opinion n° 2 - Products derived from human blood or human plasma. 12 March 1993. http:// ec.europa.eu/bepa/european-group-ethics/docs/ opinion2-en.pdf. Accessed on 01/06/2012.
21. Council of the European Communities. Council Directive 89/381/ EEC of 14 June 1989 extending the scope of Directives 65/65/ EEC and 75/319/EEC on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products and laying down special provisions for medicinal products derived from human blood or human plasma. Official Journal of the European Communities 28 June 1989; L188: 44-6.
22. Valverde JL. The political dimension of blood and plasma derivatives. Pharmaceutical Policy and Law 2005; 7: 21-33.
23. Nuffield Council on Bioethics. Human bodies: donation for medicine and research. 2011. Available at: www.nuffieldbioethics. org/sites/default/files/ Donation-full-report.pdf. Accessed on 01/06/2012.
24. Nuffield Council on Bioethics. Solidarity. Reflections on an emerging concept in bioethics. 2011. Available at: www. nuffieldbioethics.org/sites/ default/files/ncob-solidarity-report- final.pdf. Accessed on 01/06/2012.
25. Cohn EJ, Strong LE, Hughes WL, et al. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chemistry Soc 1946; 68: 459-75.
26. Farrugia A, Cassar J. Plasma-derived medicines: access and usage issues. Blood Transfus 2012; 12: 273-8.
27. NetCord, Foundation for the Accreditation of Cell Therapy (FACT). NetCord-FACT International standards for cord blood collection, banking and release for administration. Fourth edition. January 2010. www.factwebsite.org/ uploadedfiles/news/4th- edition-cord-blood-standards-4.0.pdf. Accessed on 01/06/2012.
28. Sun J, Allison J, McLaughlin C, et al. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion 2010; 50: 1980-7.
29. Parazzi V, Lazzari L, Rebulla P. Platelet gel from cord blood: A novel tool for tissue engineering. Platelets 2010; 21: 549-54.
30. European Commission. Communication from the Commission on the Precautionary Principle". COM (2000)1. 2000. Available at: http://ec.europa.eu/dgs/health-consumer/library/pub/pub07- en.pdf. Accessed on 01/06/2012.
31. Titmuss RM. The gift relationship: from human blood to social policy. London: Allen and Unwin; 1970.
32. Farrugia A, Penrod J, Bult JM. Payment, compensation and replacement - the ethics and motivation of blood and plasma donation. Vox Sang 2010; 99: 202-11.
33. Rapport FL, Maggs CJ. Titmuss and the gift relationship: altruism revisited. J Adv Nurs 2002; 40: 495-503.
34. Rossi F, Perry R, de Wit J, Evers T, Folléa G. How expanding voluntary non-remunerated blood donations would benefit patients, donors and healthcare systems? Vox Sang 2011; 101: 176-7.
35. European Union. Charter of Fundamental Rights of the European Union. Official Journal of the European Union 2000 C364: 1-22.
36. Council of Europe. Convention for the Protection of Human Rights and Dignity of Human Being with Regards to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Oviedo, 4 April 1997. conventions.coe.int/treaty/ en/treaties/html/164.htm. Accessed on 01/06/2012.